Oncology & Cancer

Researchers develop novel immunotherapy to target colorectal cancer

A Yale-led research team has developed an antibody that blocks tumors in animal models of colorectal cancer. If the finding is confirmed in clinical trials, the antibody-based treatment could become an effective weapon against ...

Oncology & Cancer

Researchers report a new target to treat prostate cancer

The drug Gefitinib is used to treat breast, lung, and other cancers by inhibiting epidermal growth factor receptor (EGFR) signaling, but it has only a limited effect on prostate cancer. EGFR, present on the cell membrane, ...

Oncology & Cancer

A new strategy for prevention of liver cancer development

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

page 1 from 16